MicrosoftTeams-image (5).png
Invea Therapeutics Research to be Showcased at the Prestigious 2023 DDW Meeting
April 26, 2023 08:10 ET | Invea Therapeutics
GUILFORD, Conn., April 26, 2023 (GLOBE NEWSWIRE) -- Invea Therapeutics (Invea), a biotechnology company developing an artificial intelligence (AI) and machine learning (ML) powered pipeline of...
Oshi Health - Digitally-enabled GI patient care
Oshi Health Raises $30M Series B Funding to Scale Access to Its Virtual Multidisciplinary Digestive Care
April 11, 2023 08:00 ET | Oshi Health
NEW YORK, April 11, 2023 (GLOBE NEWSWIRE) -- Oshi Health, the virtual specialty care company transforming gastrointestinal (GI) health outcomes and economics, today announced that it has raised $30...
nsCanary™ Featured on AGA Shark Tank
NovaScan’s nsCanary™ Tech Platform Named One of Five Finalists in AGA’s Shark Tank Competition
March 02, 2023 10:00 ET | NovaScan
Chicago, IL, March 02, 2023 (GLOBE NEWSWIRE) -- NovaScan, a clinical stage oncology company, has been selected by the American Gastroenterological Association (AGA) as a finalist in its annual Shark...
Proficient Market Insights Final Logo-01-01.png
Gastrointestinal stromal tumor Market Size 2023 Market Share, Top Companies report covers (Novartis,Bayer Aktiengesellschaft,Sun Pharmaceutical,Pfizer,NATCO Pharma), and Regional Analysis by Key Players,Segmentation and Forecast
January 24, 2023 07:03 ET | Proficient Market Insights
PUNE, Jan. 24, 2023 (GLOBE NEWSWIRE) -- "Gastrointestinal stromal tumor Market" research report focus on overall information that can help to take decisions on current market situation....
Invea Logo.jpg
Invea Therapeutics Appoints Mr. Jason Fenton to Its Board of Directors
December 06, 2022 08:10 ET | Invea Therapeutics
- Mr. Fenton augments board expertise as the Company readies for Phase 1b/2 execution of lead program targeting mast cell biology - Company also primed to advance additional programs, including a...
Palisade Bio_Logos(4.22)VSM.png
Palisade Bio Announces Reverse Stock Split
November 15, 2022 11:15 ET | Palisade Bio, Inc.
Carlsbad, CA, Nov. 15, 2022 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI)...
Imaging Agents Market Trends 2022 | North America, Europe, & APAC Industry Forecasts 2028: Graphical Research
August 10, 2022 08:00 ET | Graphical Research
Pune, India, Aug. 10, 2022 (GLOBE NEWSWIRE) -- The global imaging agents market size is estimated to increase exponentially during the forecast period, attributed to rising demand for innovative...
Research Nester  Logo
Global Gastrointestinal Radiofrequency Ablation Systems Market to Grow at CAGR ~6% During 2022-2031; Market to Elevate on Account of Increasing Prevalence of Stomach Cancer and Rising Medical Advancements
August 04, 2022 10:41 ET | Research Nester
New York, Aug. 04, 2022 (GLOBE NEWSWIRE) -- As per the estimation by the American Cancer Society, in the USA, there would presumably be about 26,380 new instances of stomach cancer (also known as...
AMR Logo.png
Global Ulcerative Colitis Market Is Expected to Reach $10.8 Billion by 2030: Says AMR
July 03, 2022 20:30 ET | Allied Market Research
Portland, OR, July 03, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Ulcerative Colitis Market was estimated at $6.2 billion in 2020 and is...
Invea Logo.jpg
Invea Therapeutics Announces Poster Presentations at Keystone Symposia Gut-Brain Axis and Digestive Disease Week (DDW2022)
March 17, 2022 08:10 ET | Invea Therapeutics
GUILFORD, Conn., March 17, 2022 (GLOBE NEWSWIRE) -- Invea Therapeutics, Inc., a global leader in applying Artificial Intelligence (AI) and Machine Learning (ML) to transform drug discovery and...